MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 74 filers reported holding MIRUM PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,855,647 | +75.8% | 58,723 | +43.9% | 0.00% | 0.0% |
Q2 2023 | $1,055,651 | -36.7% | 40,806 | -41.2% | 0.00% | 0.0% |
Q1 2023 | $1,666,436 | -49.0% | 69,377 | -58.6% | 0.00% | -66.7% |
Q4 2022 | $3,267,674 | +12.6% | 167,573 | +21.3% | 0.00% | +50.0% |
Q3 2022 | $2,903,000 | +8438.2% | 138,166 | +7701.6% | 0.00% | – |
Q2 2022 | $34,000 | +88.9% | 1,771 | +120.0% | 0.00% | – |
Q1 2022 | $18,000 | -37.9% | 805 | -56.3% | 0.00% | – |
Q4 2021 | $29,000 | +262.5% | 1,844 | +348.7% | 0.00% | – |
Q3 2021 | $8,000 | +166.7% | 411 | +140.4% | 0.00% | – |
Q2 2021 | $3,000 | -62.5% | 171 | -57.1% | 0.00% | – |
Q1 2021 | $8,000 | -57.9% | 399 | -62.7% | 0.00% | – |
Q4 2020 | $19,000 | +280.0% | 1,071 | +328.4% | 0.00% | – |
Q3 2020 | $5,000 | -66.7% | 250 | -66.6% | 0.00% | – |
Q2 2020 | $15,000 | +87.5% | 748 | +25.9% | 0.00% | – |
Q1 2020 | $8,000 | -38.5% | 594 | +10.0% | 0.00% | – |
Q4 2019 | $13,000 | +550.0% | 540 | +353.8% | 0.00% | – |
Q3 2019 | $2,000 | – | 119 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Frazier Life Sciences Management, L.P. | 6,470,392 | $204,464,387 | 13.58% |
NEA Management Company, LLC | 2,186,243 | $69,085,279 | 5.34% |
TANG CAPITAL MANAGEMENT LLC | 1,137,107 | $35,932,581 | 5.07% |
BOONE CAPITAL MANAGEMENT LLC | 389,791 | $12,317,396 | 3.89% |
Highlander Partners, L.P. | 122,980 | $3,886,168 | 3.84% |
BVF INC/IL | 4,370,024 | $138,092,758 | 3.72% |
Prosight Management, LP | 353,508 | $11,170,853 | 3.54% |
Novo Holdings A/S | 1,500,000 | $47,400,000 | 3.50% |
Nicholas Investment Partners, LP | 1,199,366 | $37,899,966 | 2.83% |
Eventide Asset Management | 3,958,579 | $125,091,097 | 2.25% |